PHIO Q2 2019 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$1M

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-499.46

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$62,000

Balance Sheet

Total Assets

$12M

Total Liabilities

$2M

Stockholders' Equity

$10M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$58,000	-100.0%
Gross Profit	-$1M	-$1M	-1.9%
Operating Income	-$2M	-$2M	-8.4%
Net Income	-$2M	-$2M	-7.0%